Skip to main content

Morphea

Veronica J. Ruston, DO Reviewed 06/2018
 


BASICS

DESCRIPTION

  • A benign inflammatory skin disorder leading to excessive collagen deposition with thickening and sclerosis of the skin and SC tissues and characteristic plaque formation

    • Lesions are w...

DIAGNOSIS

HISTORY

  • Patient notes slowly progressive skin changes over months. Coin-sized lesions slowly enlarge over weeks to months.

  • Rarely, the lesions can cause some discomfort.

  • Usually, there are mult...

TREATMENT

MEDICATION

First Line

  • Active lesions can respond to treatment, inactive lesions cannot. Relapse rates present in 25–35% (3)[B].

  • Superficial subtypes generally respond to topical treatments.

    • Reco...

ONGOING CARE

Lesions may self-resolve but this usually takes 3 to 5 years. Recommend evaluation of joints, eyes, and CNS for involvement throughout course of active disease. Many patients with plaque ...

REFERENCES

1
Mertens J, Seyger M, Thurlings R, et al. Morphea and eosinophilic fasciitis: an update. Am J Clin Dermatol.  2017;18(4):491–512. [View Abstract on OvidMedline]
2
Careta MF, Romiti R. Lo...

ADDITIONAL READING

  • Fett N, Werth VP. Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol.  2011;64(2):217–230.

  • Li SC, Torok KS, Pope E, et al; and ...

CODES

ICD10

  • L94.0 Localized scleroderma [morphea]

  • L94.1 Linear scleroderma

ICD9

701.0 Circumscribed scleroderma 

SNOMED

  • 201049004 Morphea (disorder)

  • 128458002 plaque morphea (disorder)

  • 7513007 Generalized mor...

CLINICAL PEARLS

  • Morphea lesions are well-circumscribed plaques that are firm, waxy, and have an ivory color. They are usually multiple, start small, and may slowly enlarge over time. Presence on the t...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

 
×